Pazopanib www.oncologyonline.net/?q=PazopanibA medication that helps stop the growth of new blood vessels has produced dramatic benefits for some patients with aggressive thyroid cancer, research from ... Afinitor www.oncologyonline.net/?q=AfinitorTreatment with Everolimus ( Afinitor ) prolongs progression-free survival relative to placebo in patients with metastatic renal cell carcinoma who have ... Nivolumab www.oncologyonline.net/?q=NivolumabBristol-Myers Squibb has announced long-term follow-up results ( median follow up of 20.3 months ) from the lung cancer cohort ( n=129 ) of the expanded ... Epoetin alfa www.oncologyonline.net/?q=Epoetin%20alfaA study suggests that Aranesp ( Darbepoetin alfa ) administered every three weeks with intravenous ( IV ) iron has the potential to further enhance the ...Ramucirumab www.oncologyonline.net/?q=RamucirumabThe results from the Phase III REGARD trial of Ramucirumab as a single agent in patients with advanced gastric cancer who have had disease progression after ...
Oncology News
Pazopanib www.oncologyonline.net/?q=PazopanibA medication that helps stop the growth of new blood vessels has produced dramatic benefits for some patients with aggressive thyroid cancer, research from ... Afinitor www.oncologyonline.net/?q=AfinitorTreatment with Everolimus ( Afinitor ) prolongs progression-free survival relative to placebo in patients with metastatic renal cell carcinoma who have ... Nivolumab www.oncologyonline.net/?q=NivolumabBristol-Myers Squibb has announced long-term follow-up results ( median follow up of 20.3 months ) from the lung cancer cohort ( n=129 ) of the expanded ... Epoetin alfa www.oncologyonline.net/?q=Epoetin%20alfaA study suggests that Aranesp ( Darbepoetin alfa ) administered every three weeks with intravenous ( IV ) iron has the potential to further enhance the ...Ramucirumab www.oncologyonline.net/?q=RamucirumabThe results from the Phase III REGARD trial of Ramucirumab as a single agent in patients with advanced gastric cancer who have had disease progression after ...